Sign In
Buy TVGN
$9.06
+0.590 (+6.97%)
At Close: Jun 03, 2026
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
02:50pm, Thursday, 05'th Mar 2026
WARREN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding
Tevogen Announces Reverse Stock Split
08:00am, Wednesday, 04'th Mar 2026
WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its Board of Directors (the “Board”) has approved a
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
02:20pm, Friday, 27'th Feb 2026
WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding
WARREN, N.J. and ROYAL OAK, Mich.
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
09:20am, Thursday, 26'th Feb 2026
WARREN, N.J. and ROYAL OAK, Mich.
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
03:00pm, Friday, 30'th Jan 2026
WARREN, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its Board of Directors has expressed its intention to eva
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
02:45pm, Thursday, 29'th Jan 2026
WARREN, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that the current time- and individual performance-based long-
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
09:00am, Monday, 12'th Jan 2026
Jan. 12, 2026, San Francisco. Issued from the J.P.
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
12:40pm, Monday, 22'nd Dec 2025
WARREN, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi has made a charitabl
Tevogen CEO Donates Personal Shares to Support Local Fire Department
11:10am, Friday, 19'th Dec 2025
WARREN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi has donated 50,000 s
Tevogen Bio (NASDAQ:TVGN) Trading Down 1.8% – Time to Sell?
02:41am, Friday, 12'th Dec 2025
Tevogen Bio Holdings Inc. (NASDAQ: TVGN - Get Free Report)'s share price fell 1.8% during trading on Thursday. The stock traded as low as $0.4167 and last traded at $0.43. 771,926 shares traded hands
Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company's Shares of Common Stock
03:15pm, Thursday, 11'th Dec 2025
WARREN, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi has donated 230,000
WARREN, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), is proud to recognize Curtis Patton, PhD, founding member of Tevogen's Board
Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook
02:50pm, Monday, 08'th Dec 2025
WARREN, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that it has been named to the 2025 New Jersey Power List by N
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q
02:32pm, Friday, 14'th Nov 2025
Tevogen Bio highlights continued capital-efficient execution at a time when sustainability has become a defining challenge for the biotechnology industry.
